Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00651820 · ClinicalTrials.gov registry record · Phase 4
Effect of Collagenase on Healing and Scarring
A Phase 4 study, sponsored by Healthpoint.
- Completed
- Registry status
- Phase 4
- Development phase
- 28
- Enrollment target
NCT00651820 is a Phase 4 study that has completed, run by Healthpoint. The registered enrollment target is 28 participants.
The verdict
NCT00651820, a Phase 4 study, has completed, sponsored by Healthpoint.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 28 participants
- Enrollment target
Study Summary
A study to compare the rate of complete wound closure and quality of resulting scar at 3, 6 and 9 months, between dermatome-induced skin wounds treated with Collagenase Santyl Ointment versus vehicle alone.
Interventions
- DRUG Collagenase Santyl
- DRUG Collagenase Santyl Vehicle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2008-04 |
| Est. Completion | 2010-03 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00651820
The ClinicalTrials.gov registry entry for NCT00651820 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Healthpoint, which has 25 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Collagenase Santyl is the first listed.
NCT00651820 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00651820 about?
NCT00651820 is a clinical study titled "Effect of Collagenase on Healing and Scarring". A study to compare the rate of complete wound closure and quality of resulting scar at 3, 6 and 9 months, between dermatome-induced skin wounds treated with Collagenase Santyl Ointment versus vehicle alone.
What is the current status of trial NCT00651820?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 28 participants. The study started on 2008-04. Estimated completion is 2010-03.
What interventions are being tested in trial NCT00651820?
The interventions under investigation include: Collagenase Santyl (DRUG), Collagenase Santyl Vehicle (DRUG).
Who is sponsoring clinical trial NCT00651820?
This trial is sponsored by Healthpoint, which has 25 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.